IL96696A - Process for making a history of 1-phenyl-imidazoline-2,5-deion - Google Patents

Process for making a history of 1-phenyl-imidazoline-2,5-deion

Info

Publication number
IL96696A
IL96696A IL9669690A IL9669690A IL96696A IL 96696 A IL96696 A IL 96696A IL 9669690 A IL9669690 A IL 9669690A IL 9669690 A IL9669690 A IL 9669690A IL 96696 A IL96696 A IL 96696A
Authority
IL
Israel
Prior art keywords
radical
oxide
formula
phenyl
catalyst
Prior art date
Application number
IL9669690A
Other languages
English (en)
Hebrew (he)
Other versions
IL96696A0 (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IL96696A0 publication Critical patent/IL96696A0/xx
Publication of IL96696A publication Critical patent/IL96696A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Reinforced Plastic Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IL9669690A 1989-12-22 1990-12-17 Process for making a history of 1-phenyl-imidazoline-2,5-deion IL96696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8917046A FR2656302B1 (fr) 1989-12-22 1989-12-22 Nouveau procede de preparation de l'anandron et derives de l'anandron.

Publications (2)

Publication Number Publication Date
IL96696A0 IL96696A0 (en) 1991-09-16
IL96696A true IL96696A (en) 1995-08-31

Family

ID=9388859

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9669690A IL96696A (en) 1989-12-22 1990-12-17 Process for making a history of 1-phenyl-imidazoline-2,5-deion

Country Status (24)

Country Link
US (1) US5166358A (ja)
EP (1) EP0436426B1 (ja)
JP (1) JP2836041B2 (ja)
KR (1) KR0173307B1 (ja)
CN (1) CN1048011C (ja)
AT (1) ATE107289T1 (ja)
AU (1) AU628699B2 (ja)
CA (1) CA2032988C (ja)
CZ (1) CZ281655B6 (ja)
DE (1) DE69009964T2 (ja)
DK (1) DK0436426T3 (ja)
ES (1) ES2055382T3 (ja)
FI (1) FI103203B1 (ja)
FR (1) FR2656302B1 (ja)
HU (1) HU207301B (ja)
IE (1) IE65510B1 (ja)
IL (1) IL96696A (ja)
NZ (1) NZ236621A (ja)
PL (1) PL164694B1 (ja)
PT (1) PT96313B (ja)
RU (1) RU1836356C (ja)
SK (1) SK278447B6 (ja)
UA (1) UA27220C2 (ja)
ZA (1) ZA909648B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2694290B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5656651A (en) * 1995-06-16 1997-08-12 Biophysica Inc. Androgenic directed compositions
FR2741346B1 (fr) * 1995-11-16 1997-12-19 Roussel Uclaf Nouveau procede de preparation de derives phenylimidazolidine
FR2741342B1 (fr) * 1995-11-22 1998-02-06 Roussel Uclaf Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
JPH1072446A (ja) * 1996-06-24 1998-03-17 Sumitomo Chem Co Ltd １−置換−ヒダントイン類の製造法
EP1299094A2 (en) * 2000-06-28 2003-04-09 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
ATE502298T1 (de) * 2003-12-19 2011-04-15 Univ California Verfahren und materialien zur beurteilung von prostatakrebstherapien
WO2005099693A2 (en) * 2004-02-24 2005-10-27 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
EP2656841B1 (en) * 2006-03-27 2016-08-10 The Regents of The University of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
CN102755318B (zh) 2006-03-29 2014-09-10 加利福尼亚大学董事会 二芳基硫代乙内酰脲化合物
JP5535925B2 (ja) 2007-10-26 2014-07-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物
SI3124481T1 (en) 2010-02-16 2018-06-29 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and their use
SI3305285T1 (sl) 2012-09-26 2021-03-31 Aragon Pharmaceuticals, Inc. Anti-androgeni za zdravljenje proti kastraciji odpornega ne-metastatskega raka
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
JP7201694B2 (ja) 2017-10-16 2023-01-10 アラゴン ファーマシューティカルズ，インコーポレイテッド 非転移性去勢抵抗性前立腺癌の治療のための抗アンドロゲン剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH166004A (de) * 1934-06-06 1933-12-15 Chem Fab Vormals Sandoz Verfahren zur Darstellung eines Derivates des 5,5-Phenyläthylhydantoins.
US2490813A (en) * 1944-11-29 1949-12-13 Standard Oil Co Continuous process for making aryl amines
US2759002A (en) * 1954-03-24 1956-08-14 Abbott Lab 3-benzyl hydantoin and process
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
US3914311A (en) * 1973-06-15 1975-10-21 Du Pont Preparation of aromatic secondary and tertiary amines using a nickel complex catalyst
DE2414613A1 (de) * 1974-03-26 1975-10-16 Bayer Ag 1-aryl-5-alkyliden-2,4-dioxo-imidazolidine
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
IL55774A (en) * 1977-10-28 1982-04-30 Sparamedica Ag Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture
GB1598166A (en) * 1978-05-23 1981-09-16 Lilly Industries Ltd 3,5-disubstituted hydantoin derivatives
US4764625A (en) * 1980-12-12 1988-08-16 Xerox Corporation Process for preparing arylamines
DE3382406D1 (de) * 1982-04-08 1991-10-17 Shell Int Research Neue hydantoine, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
ES2055382T3 (es) 1994-08-16
CN1048011C (zh) 2000-01-05
RU1836356C (ru) 1993-08-23
FI906366A0 (fi) 1990-12-21
SK656790A3 (en) 1997-06-04
KR910011799A (ko) 1991-08-07
FR2656302A1 (fr) 1991-06-28
CZ656790A3 (en) 1996-08-14
JPH04103573A (ja) 1992-04-06
FI906366A (fi) 1991-06-23
FR2656302B1 (fr) 1992-05-07
PL288365A1 (en) 1991-09-09
ATE107289T1 (de) 1994-07-15
US5166358A (en) 1992-11-24
AU628699B2 (en) 1992-09-17
PT96313B (pt) 1998-06-30
PL164694B1 (pl) 1994-09-30
FI103203B (fi) 1999-05-14
SK278447B6 (en) 1997-06-04
CA2032988A1 (fr) 1991-06-23
DE69009964D1 (de) 1994-07-21
UA27220C2 (uk) 2000-08-15
EP0436426A1 (fr) 1991-07-10
DE69009964T2 (de) 1994-10-13
DK0436426T3 (da) 1994-07-04
NZ236621A (en) 1992-04-28
IE65510B1 (en) 1995-11-01
CA2032988C (fr) 2003-04-29
KR0173307B1 (ko) 1999-02-01
EP0436426B1 (fr) 1994-06-15
ZA909648B (en) 1992-02-26
FI103203B1 (fi) 1999-05-14
IE904142A1 (en) 1991-07-03
CZ281655B6 (cs) 1996-12-11
HU207301B (en) 1993-03-29
AU6826590A (en) 1991-06-27
CN1052666A (zh) 1991-07-03
JP2836041B2 (ja) 1998-12-14
PT96313A (pt) 1991-09-30
IL96696A0 (en) 1991-09-16
HU908416D0 (en) 1991-07-29

Similar Documents

Publication Publication Date Title
IL96696A (en) Process for making a history of 1-phenyl-imidazoline-2,5-deion
FR2492383A1 (fr) Halogenures d'ammonium spiro-quaternaire, leur procede de prepatation et leur utilisation dans un procede de production de n-(2-pyrimidinyl) piperazinyl-alkylazospiro-alcanediones
JPH05320145A (ja) トリアジン誘導体の製造方法
JPS6046104B2 (ja) ブテン誘導体の製造方法
JPH05262749A (ja) ６−トリフルオロメチル−１，３，５トリアジン誘導体の製造方法
CA1331602C (en) Preparation process of acemetacin
EP0693482B1 (en) Process for producing hexahydropyridazine and hexahydropyridazine-1,2-dicarboxylate derivative
US4281125A (en) Quinoline catalyzed synthesis of pyridazinone pharmaceutical intermediates
CA1048024A (en) Triazino (4,3-d) (1,4) benzodiazepine-3,4,7-triones
Sauers et al. A thio-Staudinger reaction: Thermolysis of a vinyl azide in the presence of t-butyl mercaptan
US4286091A (en) Synthesis of pyridazinone pharmaceutical intermediates using diketene reactant
AU613250B2 (en) A process for preparing a naphthalene derivative
HU213387B (en) 2-substituted-5-chlor-imidazole-derivatives and process for their preparation
US4099009A (en) 1-(4-chlorophenyl)-3-(1-ureido)-2-imidazolidinone
EP0621260B1 (en) Process for producing N,N-disubstituted p-phenylenediamine derivative sulphate
JP3376481B2 (ja) ヘキサヒドロピリダジンの製造法
IE73669B1 (en) Process for the preparation of aminotriazine derivatives
US20040039203A1 (en) Process for the preparation of 1,5-disubstituted-3-amino-1,2,4,-triazoles and substituted aminoguanidines as intermediate compounds
SE448089B (sv) Sett att framstella acylhydrazoner av formylettiksyraester
JPS61233676A (ja) ２−メチル−３−カルボン酸アミドキノキサリン−１，４−ジ−ｎ−オキシドの新規な製造法
BE554447A (ja)
JPH0725769B2 (ja) 水溶性トリアゾロベンゾチアゾール誘導体またはその塩
EP0976731A1 (en) Process for producing 5-methylindolines
JPH10298163A (ja) α−アルコキシジイミノイソインドリン化合物の製造方法

Legal Events

Date Code Title Description
KB Patent renewed
HCE Change of name and address of proprietor(s)
KB Patent renewed
HCA Change of name of proprietor(s) after amalgamation
KB Patent renewed
KB Patent renewed
EXP Patent expired